Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This volume provides the reader with a detailed overview of the current state-of-the art approach of Hepatitis C management. It reviews the course of action in handling of chronic Hepatitis C patients with various HCV genotypes and treats special cases such as acute hepatitis, transplant and renal patients as well as people who inject drugs. The two volume work on Hepatitis C introduces to the topic by reviewing virology, diagnosis, epidemiology, prevention, management and elimination of HCV. The book provides a valuable source at full length for researchers and clinicians working on Hepatitis C. …mehr
This volume provides the reader with a detailed overview of the current state-of-the art approach of Hepatitis C management. It reviews the course of action in handling of chronic Hepatitis C patients with various HCV genotypes and treats special cases such as acute hepatitis, transplant and renal patients as well as people who inject drugs.
The two volume work on Hepatitis C introduces to the topic by reviewing virology, diagnosis, epidemiology, prevention, management and elimination of HCV. The book provides a valuable source at full length for researchers and clinicians working on Hepatitis C.
Prof. Angelos Hatzakis MD, PhD National and Kapodistrian University of Athens, Medical School Hepatitis B and C Public Policy Association
Inhaltsangabe
Assessment of liver disease severity.- Hepatitis C and autoimmunity.- Extrahepatic manifestations.- Treatment indications and pretreatment assessment.- Available agents - contraindications and potential drug-drug interactions.- Current management of patients with HCV genotype 1.- Current management of patients with HCV genotype 2.- Current management of patients with HCV genotype 3.- Current management of patients with HCV genotype 4.- Current management of patients with HCV genotype 5 or 6.- The role of RAVs in the current management of HCV.- Management of patients with HCV decompensated cirrhosis.- Management of patients with acute hepatitis C.- Management of transplant patients.- Management of immune complex-mediated manifestations of HCV.- Management of patients with co-infections (HBV, HIV).- Management of patients under hemodialysis.-Management of active drug addicts or patients on maintenance substitution.- Management of patients with hemoglobinopathies or bleeding disorders.- Follow-up during and after treatment.
Assessment of liver disease severity.- Hepatitis C and autoimmunity.- Extrahepatic manifestations.- Treatment indications and pretreatment assessment.- Available agents - contraindications and potential drug-drug interactions.- Current management of patients with HCV genotype 1.- Current management of patients with HCV genotype 2.- Current management of patients with HCV genotype 3.- Current management of patients with HCV genotype 4.- Current management of patients with HCV genotype 5 or 6.- The role of RAVs in the current management of HCV.- Management of patients with HCV decompensated cirrhosis.- Management of patients with acute hepatitis C.- Management of transplant patients.- Management of immune complex-mediated manifestations of HCV.- Management of patients with co-infections (HBV, HIV).- Management of patients under hemodialysis.-Management of active drug addicts or patients on maintenance substitution.- Management of patients with hemoglobinopathies or bleeding disorders.- Follow-up during and after treatment.
Assessment of liver disease severity.- Hepatitis C and autoimmunity.- Extrahepatic manifestations.- Treatment indications and pretreatment assessment.- Available agents - contraindications and potential drug-drug interactions.- Current management of patients with HCV genotype 1.- Current management of patients with HCV genotype 2.- Current management of patients with HCV genotype 3.- Current management of patients with HCV genotype 4.- Current management of patients with HCV genotype 5 or 6.- The role of RAVs in the current management of HCV.- Management of patients with HCV decompensated cirrhosis.- Management of patients with acute hepatitis C.- Management of transplant patients.- Management of immune complex-mediated manifestations of HCV.- Management of patients with co-infections (HBV, HIV).- Management of patients under hemodialysis.-Management of active drug addicts or patients on maintenance substitution.- Management of patients with hemoglobinopathies or bleeding disorders.- Follow-up during and after treatment.
Assessment of liver disease severity.- Hepatitis C and autoimmunity.- Extrahepatic manifestations.- Treatment indications and pretreatment assessment.- Available agents - contraindications and potential drug-drug interactions.- Current management of patients with HCV genotype 1.- Current management of patients with HCV genotype 2.- Current management of patients with HCV genotype 3.- Current management of patients with HCV genotype 4.- Current management of patients with HCV genotype 5 or 6.- The role of RAVs in the current management of HCV.- Management of patients with HCV decompensated cirrhosis.- Management of patients with acute hepatitis C.- Management of transplant patients.- Management of immune complex-mediated manifestations of HCV.- Management of patients with co-infections (HBV, HIV).- Management of patients under hemodialysis.-Management of active drug addicts or patients on maintenance substitution.- Management of patients with hemoglobinopathies or bleeding disorders.- Follow-up during and after treatment.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
